Download PDF
J Neurol Surg B Skull Base 2014; 75(04): 288-292
DOI: 10.1055/s-0034-1372464
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Short-Term Quality-of-Life Changes after Endoscopic Pituitary Surgery Rated with SNOT-22

Lee A. Zimmer
1   Departments of Otolaryngology, Head and Neck Surgery, University of Cincinnati (UC) College of Medicine, Cincinnati, Ohio, United States
2   Neurosensory Disorders Center, UC Neuroscience Institute, Cincinnati, Ohio, United States
,
Ojas Shah
1   Departments of Otolaryngology, Head and Neck Surgery, University of Cincinnati (UC) College of Medicine, Cincinnati, Ohio, United States
2   Neurosensory Disorders Center, UC Neuroscience Institute, Cincinnati, Ohio, United States
,
Phillip V. Theodosopoulos
2   Neurosensory Disorders Center, UC Neuroscience Institute, Cincinnati, Ohio, United States
3   Departments of Neurosurgery, University of Cincinnati (UC) College of Medicine, Cincinnati, Ohio, United States
4   Mayfield Clinic, Cincinnati, Ohio, United States
› Author Affiliations
Further Information

Publication History

01 July 2013

30 January 2014

Publication Date:
17 April 2014 (online)

Also available at
    Permissions and Reprints

Abstract

Objective Little data exist on short-term quality-of-life (QOL) outcomes, specifically sinonasal measures, after endoscopic pituitary surgery.

Design Prospective case series assessed sinonasal QOL before and after the transnasal endoscopic approach to the sella with resection of nasal cavity and sinus tissues.

Setting/Participants/Main Outcome Measures A total of 39 adults scheduled to undergo resection for a pituitary mass preoperatively completed the Sinonasal Outcome Test-22 (SNOT-22). Rating various QOL issues, testing repeated postoperatively at 1 month by 37 patients and 3 months by 35 patients, was analyzed (paired Student t test).

Results SNOT-22 scores (5-point scale; total: 110) averaged 23.4 preoperatively and 27.6 at 1 month but had significantly improved to 16.2 at 3 months (p = 0.03). Emotional well-being parameters (e.g., sadness, frustration, concentration, productivity, fatigue) significantly improved 3 months postoperatively (p < 0.05). Physiologic parameters (e.g., olfaction, obstruction, postnasal drainage) that had worsened at 1 month (< 0.05) then normalized at 3 months.

Conclusion Total ratings for sinonasal QOL shows that SNOT scores were comparable between preoperative and 1-month testing but were improved significantly at 3 months. Individual questions showed marked improvement in emotional well-being and temporary physiologic changes after surgery. Our findings give surgeons information about what patients can expect immediately after transnasal endoscopic pituitary surgery.

Keywords

quality of life - sphenoid sinus - pituitary surgery - endoscopy

Financial Disclosure

The authors did not receive any financial support for this work.


 

  • References

  • 1 Jankowski R, Auque J, Simon C, Marchal JC, Hepner H, Wayoff M. Endoscopic pituitary tumor surgery. Laryngoscope 1992; 102 (2) 198-202
    PubMedGoogle Scholar
  • 2 Jho HD, Carrau RL. Endoscopy assisted transsphenoidal surgery for pituitary adenoma. Technical note. Acta Neurochir (Wien) 1996; 138 (12) 1416-1425
    CrossrefPubMedGoogle Scholar
  • 3 Cheng RX, Tian HL, Gao WW, Li ZQ. A comparison between endoscopic trans-sphenoidal surgery and traditional trans-sphenoidal microsurgery for functioning pituitary adenomas. J Int Med Res 2011; 39 (5) 1985-1993
    CrossrefPubMedGoogle Scholar
  • 4 Goudakos JK, Markou KD, Georgalas C. Endoscopic versus microscopic trans-sphenoidal pituitary surgery: a systematic review and meta-analysis. Clin Otolaryngol 2011; 36 (3) 212-220
    CrossrefPubMedGoogle Scholar
  • 5 Messerer M, De Battista JC, Raverot G , et al. Evidence of improved surgical outcome following endoscopy for nonfunctioning pituitary adenoma removal. Neurosurg Focus 2011; 30 (4) E11
    PubMedGoogle Scholar
  • 6 Theodosopoulos PV, Leach J, Kerr RG , et al. Maximizing the extent of tumor resection during transsphenoidal surgery for pituitary macroadenomas: can endoscopy replace intraoperative magnetic resonance imaging?. J Neurosurg 2010; 112 (4) 736-743
    CrossrefPubMedGoogle Scholar
  • 7 Hart CK, Theodosopoulos PV, Zimmer LA. Olfactory changes after endoscopic pituitary tumor resection. Otolaryngol Head Neck Surg 2010; 142 (1) 95-97
    CrossrefPubMedGoogle Scholar
  • 8 Wang YY, Srirathan V, Tirr E, Kearney T, Gnanalingham KK. Nasal symptoms following endoscopic transsphenoidal pituitary surgery: assessment using the General Nasal Patient Inventory. Neurosurg Focus 2011; 30 (4) E12
    PubMedGoogle Scholar
  • 9 Rotenberg BW, Saunders S, Duggal N. Olfactory outcomes after endoscopic transsphenoidal pituitary surgery. Laryngoscope 2011; 121 (8) 1611-1613
    CrossrefPubMedGoogle Scholar
  • 10 Karabatsou K, O'Kelly C, Ganna A, Dehdashti AR, Gentili F. Outcomes and quality of life assessment in patients undergoing endoscopic surgery for pituitary adenomas. Br J Neurosurg 2008; 22 (5) 630-635
    CrossrefPubMedGoogle Scholar
  • 11 Graham SM, Iseli TA, Karnell LH, Clinger JD, Hitchon PW, Greenlee JD. Endoscopic approach for pituitary surgery improves rhinologic outcomes. Ann Otol Rhinol Laryngol 2009; 118 (9) 630-635
    CrossrefPubMedGoogle Scholar
  • 12 Suberman TA, Zanation AM, Ewend MG, Senior BA, Ebert Jr CS. Sinonasal quality-of-life before and after endoscopic, endonasal, minimally invasive pituitary surgery. Int Forum Allergy Rhinol 2011; 1 (3) 161-166
    CrossrefPubMedGoogle Scholar
  • 13 Hopkins C, Gillett S, Slack R, Lund VJ, Browne JP. Psychometric validity of the 22-item Sinonasal Outcome Test. Clin Otolaryngol 2009; 34 (5) 447-454
    CrossrefPubMedGoogle Scholar
  • 14 Doty RL. Olfaction. Annu Rev Psychol 2001; 52: 423-452
    CrossrefPubMedGoogle Scholar
  • 15 Gleason Jr JF, Case D, Rapp SR , et al. Symptom clusters in patients with newly-diagnosed brain tumors. J Support Oncol 2007; 5 (9) 427-433 , 436
    PubMedGoogle Scholar
  • 16 Ben-Shlomo A, Sheppard MC, Stephens JM, Pulgar S, Melmed S. Clinical, quality of life, and economic value of acromegaly disease control. Pituitary 2011; 14 (3) 284-294
    CrossrefPubMedGoogle Scholar
  • 17 van der Klaauw AA, Kars M, Biermasz NR , et al. Disease-specific impairments in quality of life during long-term follow-up of patients with different pituitary adenomas. Clin Endocrinol (Oxf) 2008; 69 (5) 775-784
    CrossrefPubMedGoogle Scholar